Treatment News : Common Application Now Available for HIV Patient Assistance Programs

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » September 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

September 18, 2012

Common Application Now Available for HIV Patient Assistance Programs

Uninsured HIV-positive people with low incomes may begin using a single common form to apply for multiple antiretroviral assistance programs, which was announced by Health and Human Services (HHS) Secretary Kathleen Sebelius in July at the XIX International AIDS Conference and went into effect on September 12. The Common Patient Assistance Program Application is the result of partnerships between HHS’ Health Resources and Service Administration and seven major HIV drug-producing pharmaceutical companies. Whereas people living with HIV and their health care providers have long had to complete multiple sets of paperwork to be filed with different drug companies, Sebelius explained that the new common application “streamlines and simplifies the process, reduces barriers to medication access and speeds access to lifesaving drugs.” The National Alliance of State and Territorial AIDS Directors (NASTAD) assisted in the development and implementation of the application.

To read the HHS announcement, click here.

To access the Common Patient Assistance Program Application, click here.

Search: patient assistance programs, common application, sebelius, hhs, abbott, boehringer ingelheim, bms, bristol-myers squibb, gilead sciences, johnson & johnson, merck, viiv, antiretrovirals


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (1 total)

 
[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    dambitious
    Gone
    New York


    slimcuteguy
    Asheville
    North Carolina


    sefarady
    New York
    California


    thebake
    Sioux Falls
    South Dakota
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Will decriminalizing injection drug use help end the global HIV epidemic?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.